{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T13:58:28Z","timestamp":1773237508821,"version":"3.50.1"},"reference-count":146,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2024,4,29]],"date-time":"2024-04-29T00:00:00Z","timestamp":1714348800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,4,29]],"date-time":"2024-04-29T00:00:00Z","timestamp":1714348800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Pharmacol Sin"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1038\/s41401-024-01285-w","type":"journal-article","created":{"date-parts":[[2024,4,29]],"date-time":"2024-04-29T09:01:50Z","timestamp":1714381310000},"page":"1765-1776","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Kr\u00fcppel-like factors: potential roles in blood-brain barrier dysfunction and epileptogenesis"],"prefix":"10.1038","volume":"45","author":[{"given":"Ana Beatriz","family":"Santos","sequence":"first","affiliation":[]},{"given":"Andreia","family":"Carona","sequence":"additional","affiliation":[]},{"given":"Miren","family":"Ettcheto","sequence":"additional","affiliation":[]},{"given":"Antoni","family":"Camins","sequence":"additional","affiliation":[]},{"given":"Am\u00edlcar","family":"Falc\u00e3o","sequence":"additional","affiliation":[]},{"given":"Ana","family":"Fortuna","sequence":"additional","affiliation":[]},{"given":"Joana","family":"Bicker","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2024,4,29]]},"reference":[{"key":"1285_CR1","unstructured":"World Health Organization. Epilepsy: a public health imperative. Geneva: World Health Organization. 2019. p. 1\u2013171."},{"key":"1285_CR2","unstructured":"World Health Organization. Improving the lives of people with epilepsy: a technical brief. Geneva: World Health Organization. 2022. p. 1\u201343."},{"key":"1285_CR3","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1016\/j.bbadis.2017.02.003","volume":"1863","author":"BL Clossen","year":"2017","unstructured":"Clossen BL, Reddy DS. Novel therapeutic approaches for disease-modification of epileptogenesis for curing epilepsy. Biochim Biophys Acta Mol Basis Dis. 2017;1863:1519\u201338.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"1285_CR4","doi-asserted-by":"crossref","unstructured":"Heinemann U. Epilepsy; Basic mechanisms. In: Aminoff MJ, Daroff RB, editors. Encyclopedia of the Neurological Sciences. Amsterdam: Elsevier; 2014. p. 93\u201396.","DOI":"10.1016\/B978-0-12-385157-4.00280-3"},{"key":"1285_CR5","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/B978-0-12-804279-3.00015-0","volume":"146","author":"S Fauser","year":"2017","unstructured":"Fauser S, Tumani H. Epilepsy. Handb Clin Neurol. 2017;146:259\u201366.","journal-title":"Handb Clin Neurol"},{"key":"1285_CR6","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/S0140-6736(18)32596-0","volume":"393","author":"RD Thijs","year":"2019","unstructured":"Thijs RD, Surges R, O\u2019Brien TJ, Sander JW. Epilepsy in adults. Lancet. 2019;393:689\u2013701.","journal-title":"Lancet"},{"key":"1285_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1101\/cshperspect.a022822","volume":"5","author":"A Pitkanen","year":"2015","unstructured":"Pitkanen A, Lukasiuk K, Dudek E, Staley KJ. Epileptogenesis. Cold Spring Harb Perspect Med. 2015;5:1\u201318.","journal-title":"Cold Spring Harb Perspect Med"},{"key":"1285_CR8","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s13311-014-0257-2","volume":"11","author":"A Pitk\u00e4nen","year":"2014","unstructured":"Pitk\u00e4nen A, Engel J. Past and present definitions of epileptogenesis and its biomarkers. Neurotherapeutics. 2014;11:231\u201341.","journal-title":"Neurotherapeutics"},{"key":"1285_CR9","doi-asserted-by":"publisher","first-page":"107762","DOI":"10.1016\/j.neuropharm.2019.107762","volume":"168","author":"P Klein","year":"2020","unstructured":"Klein P, Tyrlikova I. No prevention or cure of epilepsy as yet. Neuropharmacology. 2020;168:107762.","journal-title":"Neuropharmacology"},{"key":"1285_CR10","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.seizure.2020.09.015","volume":"82","author":"I Mukhtar","year":"2020","unstructured":"Mukhtar I. Inflammatory and immune mechanisms underlying epileptogenesis and epilepsy: From pathogenesis to treatment target. Seizure. 2020;82:65\u201379.","journal-title":"Seizure"},{"key":"1285_CR11","doi-asserted-by":"publisher","first-page":"89","DOI":"10.3389\/fncel.2013.00089","volume":"7","author":"RF Hunt","year":"2013","unstructured":"Hunt RF, Boychuk JA, Smith BN. Neural circuit mechanisms of post\u2013traumatic epilepsy. Front Cell Neurosci. 2013;7:89.","journal-title":"Front Cell Neurosci"},{"key":"1285_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms20010220","volume":"20","author":"SD Reddy","year":"2019","unstructured":"Reddy SD, Younus I, Sridhar V, Reddy DS. Neuroimaging biomarkers of experimental epileptogenesis and refractory epilepsy. Int J Mol Sci. 2019;20:1\u201323.","journal-title":"Int J Mol Sci"},{"key":"1285_CR13","doi-asserted-by":"crossref","unstructured":"Lukasiuk K. Epileptogenesis. In: Aminoff MJ, Daroff RB, editors. Encyclopedia of the Neurological Sciences. Amsterdam: Elsevier; 2014. p. 196\u2013199.","DOI":"10.1016\/B978-0-12-385157-4.00297-9"},{"key":"1285_CR14","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.yebeh.2015.08.037","volume":"52","author":"W L\u00f6scher","year":"2015","unstructured":"L\u00f6scher W, Hirsch LJ, Schmidt D. The enigma of the latent period in the development of symptomatic acquired epilepsy\u2014Traditional view versus new concepts. Epilepsy Behav. 2015;52:78\u201392.","journal-title":"Epilepsy Behav"},{"key":"1285_CR15","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.braindev.2012.08.007","volume":"35","author":"T Saito","year":"2013","unstructured":"Saito T, Saito Y, Sugai K, Nakagawa E, Komaki H, Okazaki T, et al. Late-onset epilepsy in children with acute febrile encephalopathy with prolonged convulsions: a clinical and encephalographic study. Brain Dev. 2013;35:531\u20139.","journal-title":"Brain Dev"},{"key":"1285_CR16","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.pharep.2017.07.012","volume":"70","author":"K \u0141ukawski","year":"2018","unstructured":"\u0141ukawski K, Andres-Mach M, Czuczwar M, \u0141uszczki JJ, Kruszy\u0144ski K, Czuczwar SJ. Mechanisms of epileptogenesis and preclinical approach to antiepileptogenic therapies. Pharmacol Rep. 2018;70:284\u201393.","journal-title":"Pharmacol Rep."},{"key":"1285_CR17","doi-asserted-by":"publisher","first-page":"271","DOI":"10.3345\/kjp.2013.56.7.271","volume":"56","author":"Y Youn","year":"2013","unstructured":"Youn Y, Sung IK, Lee IG. The role of cytokines in seizures: interleukin (IL)-1\u03b2, IL-1Ra, IL-8, and IL-10. Korean J Pediatr. 2013;56:271.","journal-title":"Korean J Pediatr"},{"key":"1285_CR18","doi-asserted-by":"publisher","first-page":"e13147","DOI":"10.1111\/bpa.13147","volume":"33","author":"Y Reiss","year":"2023","unstructured":"Reiss Y, Bauer S, David B, Devraj K, Fidan E, Hattingen E, et al. The neurovasculature as a target in temporal lobe epilepsy. Brain Pathol. 2023;33:e13147.","journal-title":"Brain Pathol"},{"key":"1285_CR19","doi-asserted-by":"crossref","unstructured":"Guo D, Zhang B, Han L, Rensing NR, Wong M. Cerebral vascular and blood brain\u2013barrier abnormalities in a mouse model of epilepsy and tuberous sclerosis complex. Epilepsia. 2024;65:483\u201396.","DOI":"10.1111\/epi.17848"},{"key":"1285_CR20","doi-asserted-by":"publisher","first-page":"591","DOI":"10.3390\/ijms21020591","volume":"21","author":"W L\u00f6scher","year":"2020","unstructured":"L\u00f6scher W, Friedman A. Structural, molecular, and functional alterations of the blood-brain barrier during epileptogenesis and epilepsy: a cause, consequence, or both? Int J Mol Sci. 2020;21:591.","journal-title":"Int J Mol Sci"},{"key":"1285_CR21","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1038\/nm.3407","volume":"19","author":"B Obermeier","year":"2013","unstructured":"Obermeier B, Daneman R, Ransohoff RM. Development, maintenance and disruption of the blood-brain barrier. Nat Med. 2013;19:1584\u201396.","journal-title":"Nat Med"},{"key":"1285_CR22","doi-asserted-by":"publisher","first-page":"106285","DOI":"10.1016\/j.yebeh.2019.04.038","volume":"101","author":"E Swissa","year":"2019","unstructured":"Swissa E, Serlin Y, Vazana U, Prager O, Friedman A. Blood-brain barrier dysfunction in status epileptics: mechanisms and role in epileptogenesis. Epilepsy Behav. 2019;101:106285.","journal-title":"Epilepsy Behav"},{"key":"1285_CR23","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1177\/0271678X231179413","volume":"43","author":"RHGJ van Lanen","year":"2023","unstructured":"van Lanen RHGJ, Haeren RHL, Staals J, Dings JTA, Schijns OEMG, Hoogland G, et al. Cerebrovascular glycocalyx damage and microcirculation impairment in patients with temporal lobe epilepsy. J Cereb Blood Flow Metab. 2023;43:1737\u201351.","journal-title":"J Cereb Blood Flow Metab"},{"key":"1285_CR24","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1111\/cns.13560","volume":"27","author":"F Zhao","year":"2021","unstructured":"Zhao F, Zhong L, Luo Y. Endothelial glycocalyx as an important factor in composition of blood-brain barrier. CNS Neurosci Ther. 2021;27:26\u201335.","journal-title":"CNS Neurosci Ther"},{"key":"1285_CR25","doi-asserted-by":"publisher","first-page":"E9429","DOI":"10.1073\/pnas.1802155115","volume":"115","author":"N Kutuzov","year":"2018","unstructured":"Kutuzov N, Flyvbjerg H, Lauritzen M. Contributions of the glycocalyx, endothelium, and extravascular compartment to the blood\u2013brain Barrier. Proc Natl Acad Sci USA. 2018;115:E9429\u201338.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1285_CR26","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1177\/0271678X17726062","volume":"38","author":"J Zhu","year":"2018","unstructured":"Zhu J, Li X, Yin J, Hu Y, Gu Y, Pan S. Glycocalyx degradation leads to blood-brain barrier dysfunction and brain edema after asphyxia cardiac arrest in rats. J Cereb Blood Flow Metab. 2018;38:1979\u201392.","journal-title":"J Cereb Blood Flow Metab"},{"key":"1285_CR27","doi-asserted-by":"publisher","first-page":"661838","DOI":"10.3389\/fncel.2021.661838","volume":"15","author":"F Takata","year":"2021","unstructured":"Takata F, Nakagawa S, Matsumoto J, Dohgu S. Blood-brain barrier dysfunction amplifies the development of neuroinflammation: understanding of cellular events in brain microvascular endothelial cells for prevention and treatment of BBB dysfunction. Front Cell Neurosci. 2021;15:661838.","journal-title":"Front Cell Neurosci"},{"key":"1285_CR28","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.neuroscience.2014.07.030","volume":"277","author":"EA van Vliet","year":"2014","unstructured":"van Vliet EA, Aronica E, Gorter JA. Role of blood-brain barrier in temporal lobe epilepsy and pharmacoresistance. Neuroscience. 2014;277:455\u201373.","journal-title":"Neuroscience"},{"key":"1285_CR29","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.1007\/s00415-012-6445-2","volume":"259","author":"R Gilad","year":"2012","unstructured":"Gilad R, Lampl Y, Eilam A, Boaz M, Loyberboim M. SPECT-DTPA as a tool for evaluating the blood-brain barrier in post-stroke seizures. J Neurol. 2012;259:2041\u20134.","journal-title":"J Neurol"},{"key":"1285_CR30","doi-asserted-by":"publisher","first-page":"382","DOI":"10.3389\/fneur.2019.00382","volume":"10","author":"NF Mendes","year":"2019","unstructured":"Mendes NF, Pansani AP, Carmanh\u00e3es ERF, Tange P, Meireles JV, Ochikubo M, et al. The blood-brain barrier breakdown during acute phase of the pilocarpine model of epilepsy Is dynamic and time-dependent. Front Neurol. 2019;10:382.","journal-title":"Front Neurol"},{"key":"1285_CR31","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1111\/cns.12405","volume":"21","author":"WY Liu","year":"2015","unstructured":"Liu WY, Wang ZB, Wang Y, Tong LC, Li Y, Wei X, et al. Increasing the permeability of the blood-brain barrier in three different models in vivo. CNS Neurosci Ther. 2015;21:568\u201374.","journal-title":"CNS Neurosci Ther"},{"key":"1285_CR32","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1177\/0004867418796955","volume":"52","author":"G Morris","year":"2018","unstructured":"Morris G, Fernandes BS, Puri BK, Walker AJ, Carvalho AF, Berk M. Leaky brain in neurological and psychiatric disorders: drivers and consequences. Aust N Z J Psychiatry. 2018;52:924\u201348.","journal-title":"Aust N Z J Psychiatry"},{"key":"1285_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-020-01054-3","volume":"10","author":"C Greene","year":"2020","unstructured":"Greene C, Hanley N, Campbell M. Blood-brain barrier associated tight junction disruption is a hallmark feature of major psychiatric disorders. Transl Psychiatry. 2020;10:373.","journal-title":"Transl Psychiatry"},{"key":"1285_CR34","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.1093\/brain\/awac461","volume":"146","author":"AR Deshwar","year":"2023","unstructured":"Deshwar AR, Cytrynbaum C, Murthy H, Zon J, Chitayat D, Volpatti J, et al. Variants in CLDN5 cause a syndrome characterized by seizures, microcephaly and brain calcifications. Brain. 2023;146:2285\u201397.","journal-title":"Brain"},{"key":"1285_CR35","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1208\/s12248-017-0096-2","volume":"19","author":"H Han","year":"2017","unstructured":"Han H, Mann A, Ekstein D, Eyal S. Breaking bad: the structure and function of the blood-brain barrier in epilepsy. AAPS J. 2017;19:973\u201388.","journal-title":"AAPS J"},{"key":"1285_CR36","doi-asserted-by":"publisher","first-page":"S13","DOI":"10.1111\/epi.17721","volume":"64","author":"P Jiruska","year":"2023","unstructured":"Jiruska P, Freestone D, Gnatkovsky V, Wang Y. An update on the seizures beget seizures theory. Epilepsia. 2023;64:S13\u2013S24.","journal-title":"Epilepsia"},{"key":"1285_CR37","doi-asserted-by":"publisher","first-page":"109","DOI":"10.3389\/fncel.2013.00109","volume":"7","author":"D Boison","year":"2013","unstructured":"Boison D, Sandau US, Ruskin DN, Kawamura M, Masino SA. Homeostatic control of brain function\u2014new approaches to understand epileptogenesis. Front Cell Neurosci. 2013;7:109.","journal-title":"Front Cell Neurosci"},{"key":"1285_CR38","doi-asserted-by":"publisher","first-page":"e135391","DOI":"10.1172\/jci.insight.135391","volume":"6","author":"F Sano","year":"2021","unstructured":"Sano F, Shigetomi E, Shinozaki Y, Tsuzukiyama H, Saito K, Mikoshiba K, et al. Reactive astrocyte-driven epileptogenesis is induced by microglia initially activated following status epilepticus. JCI Insight. 2021;6:e135391.","journal-title":"JCI Insight"},{"key":"1285_CR39","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1111\/epi.12960","volume":"56","author":"MJ Benson","year":"2015","unstructured":"Benson MJ, Manzanero S, Borges K. Complex alterations in microglial M1\/M2 markers during the development of epilepsy in two mouse models. Epilepsia. 2015;56:895\u2013905.","journal-title":"Epilepsia"},{"key":"1285_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-13812-z","volume":"10","author":"K Haruwaka","year":"2019","unstructured":"Haruwaka K, Ikegami A, Tachibana Y, Ohno N, Konishi H, Hashimoto A, et al. Dual microglia effects on blood brain barrier permeability induced by systemic inflammation. Nat Commun. 2019;10:5816.","journal-title":"Nat Commun"},{"key":"1285_CR41","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1007\/s11064-022-03773-z","volume":"48","author":"L Henning","year":"2022","unstructured":"Henning L, Unichenko P, Bedner P, Steinh\u00e4user C, Henneberger C. Astrocytes as initiators of epilepsy. Neurochem Res. 2022;48:1091\u20139.","journal-title":"Neurochem Res"},{"key":"1285_CR42","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/nature21029","volume":"541","author":"SA Liddelow","year":"2017","unstructured":"Liddelow SA, Guttenplan KA, Clarke LE, Bennett FC, Bohlen CJ, Schirmer L, et al. Neurotoxic reactive astrocytes are induced by activated microglia. Nature 2017;541:481\u20137.","journal-title":"Nature"},{"key":"1285_CR43","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1038\/nn.2535","volume":"13","author":"PI Ortinski","year":"2010","unstructured":"Ortinski PI, Dong J, Mungenast A, Yue C, Takano H, Watson DJ, et al. Selective induction of astrocytic gliosis generates deficits in neuronal inhibition. Nat Neurosci. 2010;13:584\u201391.","journal-title":"Nat Neurosci"},{"key":"1285_CR44","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1177\/1535759719844750","volume":"19","author":"JA Gorter","year":"2019","unstructured":"Gorter JA, Aronica E, van Vliet EA. The roof is leaking and a storm is raging: repairing the blood-brain barrier in the fight against epilepsy. Epilepsy Curr. 2019;19:177\u201381.","journal-title":"Epilepsy Curr"},{"key":"1285_CR45","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1016\/j.drudis.2020.04.001","volume":"25","author":"X Zhang","year":"2020","unstructured":"Zhang X, Wang D, Zhang B, Zhu J, Zhou Z, Cui L. Regulation of microglia by glutamate and its signal pathway in neurodegenerative diseases. Drug Discov Today. 2020;25:1074\u201385.","journal-title":"Drug Discov Today"},{"key":"1285_CR46","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1002\/ana.23567","volume":"72","author":"L Librizzi","year":"2012","unstructured":"Librizzi L, No\u00e8 F, Vezzani A, De Curtis M, Ravizza T. Seizure-induced brain-borne inflammation sustains seizure recurrence and blood-brain barrier damage. Ann Neurol. 2012;72:82\u201390.","journal-title":"Ann Neurol"},{"key":"1285_CR47","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1111\/j.1528-1167.2012.03637.x","volume":"53","author":"N Marchi","year":"2012","unstructured":"Marchi N, Granata T, Ghosh C, Janigro D. Blood-brain barrier dysfunction and epilepsy: pathophysiologic role and therapeutic approaches. Epilepsia. 2012;53:1877\u201386.","journal-title":"Epilepsia"},{"key":"1285_CR48","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.3390\/biomedicines10051206","volume":"10","author":"J Luo","year":"2022","unstructured":"Luo J. TGF-\u03b2 as a key modulator of astrocyte reactivity: disease relevance and therapeutic implications. Biomedicines. 2022;10:1206.","journal-title":"Biomedicines"},{"key":"1285_CR49","doi-asserted-by":"publisher","first-page":"4653","DOI":"10.1007\/s12035-018-1396-y","volume":"56","author":"LP Diniz","year":"2019","unstructured":"Diniz LP, Matias I, Siqueira M, Stipursky J, Gomes FCA. Astrocytes and the TGF-\u03b21 pathway in the healthy and diseased brain: a double-edged sword. Mol Neurobiol. 2019;56:4653\u201379.","journal-title":"Mol Neurobiol"},{"key":"1285_CR50","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.nbd.2015.02.029","volume":"78","author":"I Weissberg","year":"2015","unstructured":"Weissberg I, Wood L, Kamintsky L, Vazquez O, Milikovsky DZ, Alexander A, et al. Albumin induces excitatory synaptogenesis through astrocytic TGF-\u03b2\/ALK5 signaling in a model of acquired epilepsy following blood-brain barrier dysfunction. Neurobiol Dis. 2015;78:115\u201325.","journal-title":"Neurobiol Dis"},{"key":"1285_CR51","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.eplepsyres.2012.10.006","volume":"103","author":"Z Michalak","year":"2013","unstructured":"Michalak Z, Sano T, Engel T, Miller-Delaney SFC, Lerner-Natoli M, Henshall DC. Spatio-temporally restricted blood-brain barrier disruption after intra-amygdala kainic acid-induced status epilepticus in mice. Epilepsy Res. 2013;103:167\u201379.","journal-title":"Epilepsy Res"},{"key":"1285_CR52","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1111\/epi.13246","volume":"57","author":"EA Van Vliet","year":"2016","unstructured":"Van Vliet EA, Otte WM, Wadman WJ, Aronica E, Kooij G, De Vries HE, et al. Blood-brain barrier leakage after status epilepticus in rapamycin-treated rats I: magnetic resonance imaging. Epilepsia. 2016;57:59\u201369.","journal-title":"Epilepsia"},{"key":"1285_CR53","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1038\/nm.2127","volume":"16","author":"M Maroso","year":"2010","unstructured":"Maroso M, Balosso S, Ravizza T, Liu J, Aronica E, Iyer AM, et al. Toll-like receptor 4 and high-mobility group box-1 are involved in ictogenesis and can be targeted to reduce seizures. Nat Med. 2010;16:413\u20139.","journal-title":"Nat Med"},{"key":"1285_CR54","doi-asserted-by":"publisher","first-page":"0034","DOI":"10.1523\/ENEURO.0034-15.2015","volume":"2","author":"KP Patterson","year":"2015","unstructured":"Patterson KP, Brennan GP, Curran M, Kinney-Lang E, Dub\u00e9 C, Rashid F, et al. Rapid, coordinate inflammatory responses after experimental febrile status epilepticus: implications for epileptogenesis. eNeuro. 2015;2:0034\u201315.","journal-title":"eNeuro"},{"key":"1285_CR55","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1002\/epi4.12242","volume":"3","author":"T Ravizza","year":"2018","unstructured":"Ravizza T, Vezzani A. Pharmacological targeting of brain inflammation in epilepsy: therapeutic perspectives from experimental and clinical studies. Epilepsia Open. 2018;3:133\u201342.","journal-title":"Epilepsia Open"},{"key":"1285_CR56","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.neubiorev.2016.02.007","volume":"63","author":"EE de Vries","year":"2016","unstructured":"de Vries EE, van den Munckhof B, Braun KPJ, van Royen-Kerkhof A, de Jager W, Jansen FE. Inflammatory mediators in human epilepsy: a systematic review and meta-analysis. Neurosci Biobehav Rev. 2016;63:177\u201390.","journal-title":"Neurosci Biobehav Rev"},{"key":"1285_CR57","doi-asserted-by":"publisher","first-page":"6","DOI":"10.3389\/fcvm.2018.00006","volume":"5","author":"DR Sweet","year":"2018","unstructured":"Sweet DR, Fan L, Hsieh PN, Jain MK. Kr\u00fcppel-like factors in vascular inflammation: mechanistic insights and therapeutic potential. Front Cardiovasc Med. 2018;5:6.","journal-title":"Front Cardiovasc Med"},{"key":"1285_CR58","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.jacbts.2017.09.001","volume":"3","author":"NM Pollak","year":"2018","unstructured":"Pollak NM, Hoffman M, Goldberg IJ, Drosatos K. Kr\u00fcppel-like factors: crippling and un-crippling metabolic pathways. JACC Basic Transl Sci. 2018;3:132\u201356.","journal-title":"JACC Basic Transl Sci"},{"key":"1285_CR59","doi-asserted-by":"publisher","first-page":"2911","DOI":"10.1007\/s12035-017-0556-9","volume":"55","author":"X Tang","year":"2018","unstructured":"Tang X, Liu K, Hamblin MH, Xu Y, Yin KJ. Genetic deletion of kr\u00fcppel-Like factor 11 aggravates ischemic brain injury. Mol Neurobiol. 2018;55:2911\u201321.","journal-title":"Mol Neurobiol"},{"key":"1285_CR60","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1007\/s11011-013-9468-1","volume":"30","author":"KJ Yin","year":"2015","unstructured":"Yin KJ, Hamblin M, Fan Y, Zhang J, Chen YE. Kr\u00fcpple-like factors in the central nervous system: novel mediators in stroke. Metab Brain Dis. 2015;30:401\u201310.","journal-title":"Metab Brain Dis"},{"key":"1285_CR61","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-022-02638-0","volume":"19","author":"C Zhou","year":"2022","unstructured":"Zhou C, Sun P, Hamblin MH, Yin KJ. Genetic deletion of Kr\u00fcppel-like factor 11 aggravates traumatic brain injury. J Neuroinflammation. 2022;19:281.","journal-title":"J Neuroinflammation"},{"key":"1285_CR62","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1152\/physrev.00058.2009","volume":"90","author":"BB McConnell","year":"2010","unstructured":"McConnell BB, Yang VW. Mammalian Kr\u00fcppel-like factors in health and diseases. Physiol Rev. 2010;90:1337\u201381.","journal-title":"Physiol Rev"},{"key":"1285_CR63","doi-asserted-by":"publisher","first-page":"448","DOI":"10.3390\/metabo13030448","volume":"13","author":"S Kotlyarov","year":"2023","unstructured":"Kotlyarov S, Kotlyarova A. Participation of Kr\u00fcppel-like factors in atherogenesis. Metabolites. 2023;13:448.","journal-title":"Metabolites"},{"key":"1285_CR64","doi-asserted-by":"publisher","first-page":"2383","DOI":"10.3390\/ijms18112383","volume":"18","author":"P Jha","year":"2017","unstructured":"Jha P, Das H. KLF2 in regulation of NF-\u03baB-mediated immune cell function and inflammation. Int J Mol Sci. 2017;18:2383.","journal-title":"Int J Mol Sci"},{"key":"1285_CR65","doi-asserted-by":"publisher","first-page":"2289","DOI":"10.1093\/gbe\/evv141","volume":"7","author":"JS Presnell","year":"2015","unstructured":"Presnell JS, Schnitzler CE, Browne WE. KLF\/SP transcription factor family evolution: expansion, diversification, and innovation in eukaryotes. Genome Biol Evol. 2015;7:2289\u2013309.","journal-title":"Genome Biol Evol"},{"key":"1285_CR66","doi-asserted-by":"publisher","DOI":"10.1186\/1742-2094-7-68","volume":"7","author":"DK Kaushik","year":"2010","unstructured":"Kaushik DK, Gupta M, Das S, Basu A. Kr\u00fcppel-like factor 4, a novel transcription factor regulates microglial activation and subsequent neuroinflammation. J Neuroinflammation. 2010;7:68.","journal-title":"J Neuroinflammation"},{"key":"1285_CR67","first-page":"54","volume":"85","author":"KT Turpaev","year":"2020","unstructured":"Turpaev KT. Transcription factor KLF2 and its role in the regulation of inflammatory processes. Biochemistry. 2020;85:54\u201367.","journal-title":"Biochemistry"},{"key":"1285_CR68","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1016\/S0092-8674(00)82001-2","volume":"87","author":"VV Ogryzko","year":"1996","unstructured":"Ogryzko VV, Schiltz RL, Russanova V, Howard BH, Nakatani Y. The transcriptional coactivators p300 and CBP are histone acetyltransferases. Cell. 1996;87:953\u20139.","journal-title":"Cell"},{"key":"1285_CR69","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1093\/eurheartj\/ehn603","volume":"30","author":"D Pons","year":"2009","unstructured":"Pons D, De Vries FR, Van Den Elsen PJ, Heijmans BT, Quax PHA, Jukema JW. Epigenetic histone acetylation modifiers in vascular remodelling: new targets for therapy in cardiovascular disease. Eur Heart J. 2009;30:266\u201377.","journal-title":"Eur Heart J"},{"key":"1285_CR70","doi-asserted-by":"publisher","first-page":"147988","DOI":"10.1016\/j.brainres.2022.147988","volume":"1790","author":"Y Chen","year":"2022","unstructured":"Chen Y, Chen J, Chen Y, Li Y. miR-146a\/KLF4 axis in epileptic mice: a novel regulator of synaptic plasticity involving STAT3 signaling. Brain Res. 2022;1790:147988.","journal-title":"Brain Res"},{"key":"1285_CR71","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/brainsci8120226","volume":"8","author":"R Thompson","year":"2018","unstructured":"Thompson R, Chan C. NRSF and its epigenetic effectors: new treatments for neurological disease. Brain Sci. 2018;8:1\u201312.","journal-title":"Brain Sci"},{"key":"1285_CR72","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/biom13101477","volume":"13","author":"L Jin","year":"2023","unstructured":"Jin L, Liu Y, Wu Y, Huang Y, Zhang D. REST is not resting: REST\/NRSF in health and disease. Biomolecules. 2023;13:1\u201323.","journal-title":"Biomolecules"},{"key":"1285_CR73","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fncel.2019.00580","volume":"13","author":"E Carminati","year":"2020","unstructured":"Carminati E, Buffolo F, Rocchi A, Michetti C, Cesca F, Benfenati F. Mild inactivation of RE-1 Silencing Transcription Factor (REST) reduces susceptibility to kainic acid-induced seizures. Front Cell Neurosci. 2020;13:1\u201310.","journal-title":"Front Cell Neurosci"},{"key":"1285_CR74","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.yebeh.2019.02.012","volume":"94","author":"V Navarrete-Modesto","year":"2019","unstructured":"Navarrete-Modesto V, Orozco-Su\u00e1rez S, Alonso-Vanegas M, Feria-Romero IA, Rocha L. REST\/NRSF transcription factor is overexpressed in hippocampus of patients with drug-resistant mesial temporal lobe epilepsy. Epilepsy Behav. 2019;94:118\u201323.","journal-title":"Epilepsy Behav"},{"key":"1285_CR75","doi-asserted-by":"publisher","first-page":"e01267","DOI":"10.7554\/eLife.01267","volume":"3","author":"S McClelland","year":"2014","unstructured":"McClelland S, Brennan GP, Dub\u00e9 C, Rajpara S, Iyer S, Richichi C, et al. The transcription factor NRSF contributes to epileptogenesis by selective repression of a subset of target genes. Elife. 2014;3:e01267.","journal-title":"Elife"},{"key":"1285_CR76","doi-asserted-by":"publisher","first-page":"1267609","DOI":"10.3389\/fncel.2023.1267609","volume":"17","author":"G Natali","year":"2023","unstructured":"Natali G, Michetti C, Krawczun-Rygmaczewska A, Floss T, Cesca F, Benfenati F. Conditional knockout of REST\/NRSF in excitatory neurons reduces seizure susceptibility to chemical kindling. Front Cell Neurosci. 2023;17:1267609.","journal-title":"Front Cell Neurosci"},{"key":"1285_CR77","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1083\/jcb.201010126","volume":"193","author":"I Prada","year":"2011","unstructured":"Prada I, Marchaland J, Podini P, Magrassi L, D\u2019Alessandro R, Bezzi P, et al. REST\/NRSF governs the expression of dense-core vesicle gliosecretion in astrocytes. J Cell Biol. 2011;193:537\u201349.","journal-title":"J Cell Biol"},{"key":"1285_CR78","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1111\/nan.12137","volume":"40","author":"D Schiffer","year":"2014","unstructured":"Schiffer D, Caldera V, Mellai M, Conforti P, Cattaneo E, Zuccato C. Repressor element-1 silencing transcription factor (REST) is present in human control and Huntington\u2019s disease neurones. Neuropathol Appl Neurobiol. 2014;40:899\u2013910.","journal-title":"Neuropathol Appl Neurobiol"},{"key":"1285_CR79","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1523\/JNEUROSCI.18-04-01280.1998","volume":"18","author":"K Palm","year":"1998","unstructured":"Palm K, Belluardo N, Metsis M, Timmusk T. Neuronal expression of zinc finger transcription factor REST\/NRSF\/XBR gene. J Neurosci. 1998;18:1280\u201396.","journal-title":"J Neurosci"},{"key":"1285_CR80","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.neuron.2014.03.015","volume":"82","author":"JZ Parrish","year":"2014","unstructured":"Parrish JZ, Kim CC, Tang L, Bergquist S, Wang T, DeRisi JL, et al. Kr\u00fcppel mediates the selective rebalancing of ion channel expression. Neuron. 2014;82:537\u201344.","journal-title":"Neuron"},{"key":"1285_CR81","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.neuroscience.2011.02.046","volume":"186","author":"KH Jeong","year":"2011","unstructured":"Jeong KH, Lee KE, Kim SY, Cho KO. Upregulation of Kr\u00fcppel-like factor 6 in the mouse hippocampus after pilocarpine-induced status epilepticus. Neuroscience. 2011;186:170\u20138.","journal-title":"Neuroscience"},{"key":"1285_CR82","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1097\/NEN.0b013e3181eac1f5","volume":"69","author":"KA Orlova","year":"2010","unstructured":"Orlova KA, Tsai V, Baybis M, Heuer GG, Sisodiya S, Thom M, et al. Early progenitor cell marker expression distinguishes type II from type I focal cortical dysplasias. J Neuropathol Exp Neurol. 2010;69:850\u201363.","journal-title":"J Neuropathol Exp Neurol"},{"key":"1285_CR83","doi-asserted-by":"publisher","first-page":"76415","DOI":"10.18632\/oncotarget.13001","volume":"7","author":"K Yao","year":"2016","unstructured":"Yao K, Duan Z, Zhou J, Li L, Zhai F, Dong Y, et al. Clinical and immunohistochemical characteristics of type II and type I focal cortical dysplasia. Oncotarget. 2016;7:76415\u201322.","journal-title":"Oncotarget"},{"key":"1285_CR84","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.brainres.2008.11.013","volume":"1250","author":"S Zhu","year":"2009","unstructured":"Zhu S, Tai C, MacVicar BA, Jia W, Cynader MS. Glutamatergic stimulation triggers rapid Kr\u00fcpple-like factor 4 expression in neurons and the overexpression of KLF4 sensitizes neurons to NMDA-induced caspase-3 activity. Brain Res. 2009;1250:49\u201362.","journal-title":"Brain Res"},{"key":"1285_CR85","doi-asserted-by":"publisher","first-page":"13507","DOI":"10.1080\/21655979.2022.2078549","volume":"13","author":"S Zhou","year":"2022","unstructured":"Zhou S, Li J, Zhang XN, Xiong W. MicroRNA-124 modulates neuroinflammation in acute methanol poisoning rats via targeting Kr\u00fcppel-like factor-6. Bioengineered. 2022;13:13507\u201319.","journal-title":"Bioengineered"},{"key":"1285_CR86","doi-asserted-by":"publisher","first-page":"3785","DOI":"10.1007\/s12035-020-01971-w","volume":"57","author":"J \u00c1vila-Mendoza","year":"2020","unstructured":"\u00c1vila-Mendoza J, Subramani A, Sifuentes CJ, Denver RJ. Molecular mechanisms for Kr\u00fcppel-like Factor 13 actions in hippocampal neurons. Mol Neurobiol. 2020;57:3785\u2013802.","journal-title":"Mol Neurobiol"},{"key":"1285_CR87","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1073\/pnas.94.4.1177","volume":"94","author":"J Tapia-Ram\u00edrez","year":"1997","unstructured":"Tapia-Ram\u00edrez J, Eggen BJL, Peral-Rubio MJ, Toledo-Aral JJ, Mandel G. A single zinc finger motif in the silencing factor REST represses the neural-specific type II sodium channel promoter. Proc Natl Acad Sci USA. 1997;94:1177\u201382.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1285_CR88","doi-asserted-by":"publisher","first-page":"14652","DOI":"10.1523\/JNEUROSCI.2934-09.2009","volume":"29","author":"M Yeo","year":"2009","unstructured":"Yeo M, Berglund K, Augustine G, Liedtke W. Novel repression of Kcc2 transcription by REST-RE-1 controls developmental switch in neuronal chloride. J Neurosci. 2009;29:14652\u201362.","journal-title":"J Neurosci"},{"key":"1285_CR89","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41401-023-01149-9","volume":"45","author":"E McMoneagle","year":"2024","unstructured":"McMoneagle E, Zhou J, Zhang S, Huang W, Josiah SS, Ding K, et al. Neuronal K+\u2009-Cl- cotransporter KCC2 as a promising drug target for epilepsy treatment. Acta Pharmacol Sin. 2024;45:1\u201322.","journal-title":"Acta Pharmacol Sin"},{"key":"1285_CR90","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.nbd.2006.04.020","volume":"24","author":"EM Spencer","year":"2006","unstructured":"Spencer EM, Chandler KE, Haddley K, Howard MR, Hughes D, Belyaev ND, et al. Regulation and role of REST and REST4 variants in modulation of gene expression in in vivo and in vitro in epilepsy models. Neurobiol Dis. 2006;24:41\u201352.","journal-title":"Neurobiol Dis"},{"key":"1285_CR91","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1002\/ana.22479","volume":"70","author":"S McClelland","year":"2011","unstructured":"McClelland S, Flynn C, Dub\u00e9 C, Richichi C, Zha Q, Ghestem A, et al. Neuron-restrictive silencer factor-mediated hyperpolarization-activated cyclic nucleotide gated channelopathy in experimental temporal lobe epilepsy. Ann Neurol. 2011;70:454\u201365.","journal-title":"Ann Neurol"},{"key":"1285_CR92","doi-asserted-by":"publisher","first-page":"2158","DOI":"10.1093\/cercor\/bhq284","volume":"21","author":"XL Hu","year":"2011","unstructured":"Hu XL, Cheng X, Cai L, Tan GH, Xu L, Feng XY, et al. Conditional deletion of NRSF in forebrain neurons accelerates epileptogenesis in the kindling model. Cereb Cortex. 2011;21:2158\u201365.","journal-title":"Cereb Cortex"},{"key":"1285_CR93","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/epi.13783","volume":"58","author":"E Aronica","year":"2017","unstructured":"Aronica E, Bauer S, Bozzi Y, Caleo M, Dingledine R, Gorter JA, et al. Neuroinflammatory targets and treatments for epilepsy validated in experimental models. Epilepsia. 2017;58:27\u201338.","journal-title":"Epilepsia"},{"key":"1285_CR94","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1111\/bpa.12831","volume":"30","author":"X Zhang","year":"2020","unstructured":"Zhang X, Tang X, Ma F, Fan Y, Sun P, Zhu T, et al. Endothelium-targeted overexpression of Kr\u00fcppel-like factor 11 protects the blood-brain barrier function after ischemic brain injury. Brain Pathol. 2020;30:746\u201365.","journal-title":"Brain Pathol"},{"key":"1285_CR95","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1016\/j.ajpath.2013.01.029","volume":"182","author":"L Nayak","year":"2013","unstructured":"Nayak L, Goduni L, Takami Y, Sharma N, Kapil P, Jain MK, et al. Kruppel-like factor 2 is a transcriptional regulator of chronic and acute inflammation. Am J Pathol. 2013;182:1696\u2013704.","journal-title":"Am J Pathol"},{"key":"1285_CR96","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1084\/jem.20031132","volume":"199","author":"S SenBanerjee","year":"2004","unstructured":"SenBanerjee S, Lin Z, Atkins GB, Greif DM, Rao RM, Kumar A, et al. KLF2 Is a novel transcriptional regulator of endothelial proinflammatory activation. J Exp Med. 2004;199:1305\u201315.","journal-title":"J Exp Med"},{"key":"1285_CR97","doi-asserted-by":"publisher","first-page":"2736","DOI":"10.1172\/JCI45444","volume":"121","author":"X Liao","year":"2011","unstructured":"Liao X, Sharma N, Kapadia F, Zhou G, Lu Y, Hong H, et al. Kr\u00fcppel-like factor 4 regulates macrophage polarization. J Clin Invest. 2011;121:2736\u201349.","journal-title":"J Clin Invest"},{"key":"1285_CR98","doi-asserted-by":"publisher","first-page":"1952","DOI":"10.1161\/ATVBAHA.110.211474","volume":"30","author":"Z Lin","year":"2010","unstructured":"Lin Z, Natesan V, Shi H, Dong F, Kawanami D, Mahabeleshwar GH, et al. Kruppel-like factor 2 regulates endothelial barrier function. Arterioscler Thromb Vasc Biol. 2010;30:1952\u20139.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1285_CR99","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1152\/ajpheart.00712.2012","volume":"304","author":"H Shi","year":"2013","unstructured":"Shi H, Sheng B, Zhang F, Wu C, Zhang R, Zhu J, et al. Kruppel-like factor 2 protects against ischemic stroke by regulating endothelial blood brain barrier function. Am J Physiol Heart Circ Physiol. 2013;304:796\u2013805.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"1285_CR100","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s00418-013-1134-5","volume":"141","author":"JH Park","year":"2014","unstructured":"Park JH, Riew TR, Shin YJ, Park JM, Cho JM, Lee MY. Induction of Kr\u00fcppel-like factor 4 expression in reactive astrocytes following ischemic injury in vitro and in vivo. Histochem Cell Biol. 2014;141:33\u201342.","journal-title":"Histochem Cell Biol"},{"key":"1285_CR101","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-023-02742-9","volume":"20","author":"C Wang","year":"2023","unstructured":"Wang C, Li L. The critical role of KLF4 in regulating the activation of A1\/A2 reactive astrocytes following ischemic stroke. J Neuroinflammation. 2023;20:40.","journal-title":"J Neuroinflammation"},{"key":"1285_CR102","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-020-01780-x","volume":"17","author":"X Zhang","year":"2020","unstructured":"Zhang X, Wang L, Han Z, Dong J, Pang D, Fu Y, et al. KLF4 alleviates cerebral vascular injury by ameliorating vascular endothelial inflammation and regulating tight junction protein expression following ischemic stroke. J Neuroinflammation. 2020;17:107.","journal-title":"J Neuroinflammation"},{"key":"1285_CR103","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1002\/jcp.24523","volume":"229","author":"J Ma","year":"2014","unstructured":"Ma J, Wang P, Liu Y, Zhao L, Li Z, Xue Y. Kr\u00fcppel-like factor 4 regulates blood-tumor barrier permeability via ZO-1, occludin and claudin-5. J Cell Physiol. 2014;229:916\u201326.","journal-title":"J Cell Physiol"},{"key":"1285_CR104","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1161\/CIRCRESAHA.110.219592","volume":"107","author":"CE Cowan","year":"2010","unstructured":"Cowan CE, Kohler EE, Dugan TA, Mirza MK, Malik AB, Wary KK. Kruppel-like factor-4 transcriptionally regulates VE-cadherin expression and endothelial barrier function. Circ Res. 2010;107:959\u201366.","journal-title":"Circ Res"},{"key":"1285_CR105","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.bbrc.2018.03.161","volume":"499","author":"M Wen","year":"2018","unstructured":"Wen M, Ye J, Han Y, Huang L, Yang H, Jiang W, et al. Hypertonic saline regulates microglial M2 polarization via miR-200b\/KLF4 in cerebral edema treatment. Biochem Biophys Res Commun. 2018;499:345\u201353.","journal-title":"Biochem Biophys Res Commun"},{"key":"1285_CR106","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1111\/imcb.12455","volume":"99","author":"X Wang","year":"2021","unstructured":"Wang X, Li H, Chen S, He J, Chen W, Ding Y, et al. P300\/CBP-associated factor (PCAF) attenuated M1 macrophage inflammatory responses possibly through KLF2 and KLF4. Immunol Cell Biol. 2021;99:724\u201336.","journal-title":"Immunol Cell Biol"},{"key":"1285_CR107","doi-asserted-by":"publisher","first-page":"109191","DOI":"10.1016\/j.intimp.2022.109191","volume":"112","author":"NK El-Deeb","year":"2022","unstructured":"El-Deeb NK, El-Tanbouly DM, Khattab MA, EL-Yamany MF, Mohamed AF. Crosstalk between PI3K\/AKT\/KLF4 signaling and microglia M1\/M2 polarization as a novel mechanistic approach towards flibanserin repositioning in Parkinson\u2019s disease. Int Immunopharmacol. 2022;112:109191.","journal-title":"Int Immunopharmacol"},{"key":"1285_CR108","doi-asserted-by":"publisher","first-page":"6011","DOI":"10.4049\/jimmunol.1402797","volume":"194","author":"N Kapoor","year":"2015","unstructured":"Kapoor N, Niu J, Saad Y, Kumar S, Sirakova T, Becerra E, et al. Transcription factors STAT6 and KLF4 implement macrophage polarization via the dual catalytic powers of MCPIP. J Immunol. 2015;194:6011\u201323.","journal-title":"J Immunol"},{"key":"1285_CR109","doi-asserted-by":"publisher","first-page":"27189","DOI":"10.1074\/jbc.M112.346932","volume":"287","author":"A Ghosh","year":"2012","unstructured":"Ghosh A, Pahan K. Gemfibrozil, a lipid-lowering drug, induces suppressor of cytokine signaling 3 in glial cells: implications for neurodegenerative disorders. J Biol Chem. 2012;287:27189\u2013203.","journal-title":"J Biol Chem"},{"key":"1285_CR110","doi-asserted-by":"publisher","DOI":"10.1186\/1742-2094-9-57","volume":"9","author":"DK Kaushik","year":"2012","unstructured":"Kaushik DK, Mukhopadhyay R, Kumawat KL, Gupta M, Basu A. Therapeutic targeting of Kr\u00fcppel-like factor 4 abrogates microglial activation. J Neuroinflammation. 2012;9:57.","journal-title":"J Neuroinflammation"},{"key":"1285_CR111","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1111\/jnc.12382","volume":"127","author":"DK Kaushik","year":"2013","unstructured":"Kaushik DK, Thounaojam MC, Kumawat KL, Gupta M, Basu A. Interleukin-1\u03b2 orchestrates underlying inflammatory responses in microglia via Kr\u00fcppel-like factor 4. J Neurochem. 2013;127:233\u201344.","journal-title":"J Neurochem"},{"key":"1285_CR112","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.jneuroim.2018.07.013","volume":"323","author":"R Uta","year":"2018","unstructured":"Uta R, Fran\u00e7ois C, Marvin H, Philipp A, Andrea PP, Henrik W, et al. Anti-inflammatory properties of Honokiol in activated primary microglia and astrocytes. J Neuroimmunol. 2018;323:78\u201386.","journal-title":"J Neuroimmunol"},{"key":"1285_CR113","doi-asserted-by":"publisher","first-page":"110426","DOI":"10.1016\/j.intimp.2023.110426","volume":"121","author":"Z Zhuo","year":"2023","unstructured":"Zhuo Z, Wang Y, Kong H, Fu T. GKLF, a transcriptional activator of Txnip, drives microglia activation in kainic acid-induced murine models of epileptic seizures. Int Immunopharmacol. 2023;121:110426.","journal-title":"Int Immunopharmacol"},{"key":"1285_CR114","doi-asserted-by":"publisher","first-page":"33994","DOI":"10.1074\/jbc.M701847200","volume":"282","author":"PM Evans","year":"2007","unstructured":"Evans PM, Zhang W, Chen X, Yang J, Bhakat KK, Liu C. Kruppel-like factor 4 is acetylated by p300 and regulates gene transcription via modulation of histone acetylation. J Biol Chem. 2007;282:33994\u20134002.","journal-title":"J Biol Chem"},{"key":"1285_CR115","doi-asserted-by":"publisher","first-page":"12876","DOI":"10.1074\/jbc.M113.535831","volume":"289","author":"Y Zhang","year":"2014","unstructured":"Zhang Y, Lei CQ, Hu YH, Xia T, Li M, Zhong B, et al. Kr\u00fcppel-like factor 6 is a co-activator of NF-\u03baB that mediates p65-dependent transcription of selected downstream genes. J Biol Chem. 2014;289:12876\u201385.","journal-title":"J Biol Chem"},{"key":"1285_CR116","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-021-03465-6","volume":"12","author":"F Buffolo","year":"2021","unstructured":"Buffolo F, Petrosino V, Albini M, Moschetta M, Carlini F, Floss T, et al. Neuroinflammation induces synaptic scaling through IL-1\u03b2-mediated activation of the transcriptional repressor REST\/NRSF. Cell Death Dis. 2021;12:180.","journal-title":"Cell Death Dis"},{"key":"1285_CR117","doi-asserted-by":"publisher","first-page":"e4","DOI":"10.1017\/erm.2016.3","volume":"18","author":"W Wang","year":"2016","unstructured":"Wang W, Wang X, Chen L, Zhang Y, Xu Z, Liu J, et al. The microRNA miR-124 suppresses seizure activity and regulates CREB1 activity. Expert Rev Mol Med. 2016;18:e4.","journal-title":"Expert Rev Mol Med"},{"key":"1285_CR118","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1093\/cvr\/cvn007","volume":"78","author":"TT Tuomisto","year":"2008","unstructured":"Tuomisto TT, Lumivuori H, Kansanen E, H\u00e4kkinen SK, Turunen MP, Van Thienen JV, et al. Simvastatin has an anti-inflammatory effect on macrophages via upregulation of an atheroprotective transcription factor, Kruppel-like factor 2. Cardiovasc Res. 2008;78:175\u201384.","journal-title":"Cardiovasc Res"},{"key":"1285_CR119","doi-asserted-by":"publisher","first-page":"e96005","DOI":"10.1371\/journal.pone.0096005","volume":"9","author":"T Maejima","year":"2014","unstructured":"Maejima T, Inoue T, Kanki Y, Kohro T, Li G, Ohta Y, et al. Direct evidence for pitavastatin induced chromatin structure change in the KLF4 gene in endothelial cells. PLoS One. 2014;9:e96005.","journal-title":"PLoS One"},{"key":"1285_CR120","doi-asserted-by":"publisher","first-page":"26199","DOI":"10.1074\/jbc.M110.103127","volume":"285","author":"N Ohnesorge","year":"2010","unstructured":"Ohnesorge N, Viemann D, Schmidt N, Czymai T, Spiering D, Schmolke M, et al. Erk5 activation elicits a vasoprotective endothelial phenotype via induction of Kruppel-like factor 4 (KLF4). J Biol Chem. 2010;285:26199\u2013210.","journal-title":"J Biol Chem"},{"key":"1285_CR121","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1172\/JCI41384","volume":"120","author":"DX Bu","year":"2010","unstructured":"Bu DX, Tarrio M, Grabie N, Zhang Y, Yamazaki H, Stavrakis G, et al. Statin-induced Kr\u00fcppel-like factor 2 expression in human and mouse T cells reduces inflammatory and pathogenic responses. J Clin Invest. 2010;120:1961\u201370.","journal-title":"J Clin Invest"},{"key":"1285_CR122","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1161\/CIRCULATIONAHA.104.525774","volume":"112","author":"S Sen-Banerjee","year":"2005","unstructured":"Sen-Banerjee S, Mir S, Lin Z, Hamik A, Atkins GB, Das H, et al. Kruppel-like factor 2 as a novel mediator of statin effects in endothelial cells. Circulation. 2005;112:720\u20136.","journal-title":"Circulation"},{"key":"1285_CR123","doi-asserted-by":"publisher","first-page":"2378","DOI":"10.1111\/j.1476-5381.2011.01734.x","volume":"165","author":"Y Wang","year":"2012","unstructured":"Wang Y, Zhao B, Zhang Y, Tang Z, Shen Q, Zhang Y, et al. Kr\u00fcppel-like factor 4 is induced by rapamycin and mediates the anti-proliferative effect of rapamycin in rat carotid arteries after balloon injury. Br J Pharmacol. 2012;165:2378\u201388.","journal-title":"Br J Pharmacol"},{"key":"1285_CR124","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-018-1193-6","volume":"15","author":"S Chen","year":"2018","unstructured":"Chen S, Ye J, Chen X, Shi J, Wu W, Lin W, et al. Valproic acid attenuates traumatic spinal cord injury-induced inflammation via STAT1 and NF-\u03baB pathway dependent of HDAC3. J Neuroinflammation. 2018;15:150.","journal-title":"J Neuroinflammation"},{"key":"1285_CR125","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1038\/jcbfm.2010.195","volume":"31","author":"Z Wang","year":"2011","unstructured":"Wang Z, Leng Y, Tsai LK, Leeds P, Chuang DM. Valproic acid attenuates blood-brain barrier disruption in a rat model of transient focal cerebral ischemia: the roles of HDAC and MMP-9 inhibition. J Cereb Blood Flow Metab. 2011;31:52\u20137.","journal-title":"J Cereb Blood Flow Metab"},{"key":"1285_CR126","doi-asserted-by":"publisher","first-page":"13669","DOI":"10.18632\/aging.205217","volume":"15","author":"F Gong","year":"2023","unstructured":"Gong F, Shi Q, Mou X, Wang K, Wang Q, Wang H. Atorvastatin mitigates memory deficits and brain monocyte infiltration in chronic hypercholesterolemia. Aging 2023;15:13669\u201379.","journal-title":"Aging"},{"key":"1285_CR127","doi-asserted-by":"publisher","first-page":"26714","DOI":"10.1074\/jbc.C500144200","volume":"280","author":"KM Parmar","year":"2005","unstructured":"Parmar KM, Nambudiri V, Dai G, Larman HB, Gimbrone MA, Garc\u00eda-Carde\u00f1a G. Statins exert endothelial atheroprotective effects via the KLF2 transcription factor. J Biol Chem. 2005;280:26714\u20139.","journal-title":"J Biol Chem"},{"key":"1285_CR128","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1212\/WNL.0000000000001814","volume":"85","author":"J Guo","year":"2015","unstructured":"Guo J, Li J, Zhou M, Qin F, Zhang S, Wu B, et al. Statin treatment reduces the risk of poststroke seizures. Neurology 2015;85:701\u20137.","journal-title":"Neurology"},{"key":"1285_CR129","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1111\/epi.17303","volume":"63","author":"Y Hufthy","year":"2022","unstructured":"Hufthy Y, Bharadwaj M, Gupta S, Hussain D, Joseph PJS, Khan A, et al. Statins as antiepileptogenic drugs: analyzing the evidence and identifying the most promising statin. Epilepsia 2022;63:1889\u201398.","journal-title":"Epilepsia"},{"key":"1285_CR130","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1212\/WNL.0b013e3181f96253","volume":"75","author":"M Etminan","year":"2010","unstructured":"Etminan M, Samii A, Brophy JM. Statin use and risk of epilepsy: a nested case-control study. Neurology 2010;75:1496\u2013500.","journal-title":"Neurology"},{"key":"1285_CR131","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/s40263-018-0501-0","volume":"32","author":"FJ Lin","year":"2018","unstructured":"Lin FJ, Lin HW, Ho YF. Effect of statin intensity on the risk of epilepsy after ischaemic stroke: real-world evidence from population-based health claims. CNS Drugs. 2018;32:367\u201376.","journal-title":"CNS Drugs"},{"key":"1285_CR132","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.yebeh.2017.10.021","volume":"78","author":"CV de Oliveira","year":"2018","unstructured":"de Oliveira CV, Grigoletto J, Canzian JM, Duarte MMMF, Duarte T, Furian AF, et al. Effect of atorvastatin on behavioral alterations and neuroinflammation during epileptogenesis. Epilepsy Behav. 2018;78:109\u201317.","journal-title":"Epilepsy Behav"},{"key":"1285_CR133","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.yebeh.2010.07.024","volume":"19","author":"G \u00dcz\u00fcm","year":"2010","unstructured":"\u00dcz\u00fcm G, Akg\u00fcn-Dar K, Aksu U. The effects of atorvastatin on memory deficit and seizure susceptibility in pentylentetrazole-kindled rats. Epilepsy Behav. 2010;19:284\u20139.","journal-title":"Epilepsy Behav"},{"key":"1285_CR134","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.lfs.2018.09.025","volume":"211","author":"A Iqubal","year":"2018","unstructured":"Iqubal A, Sharma S, Sharma K, Bhavsar A, Hussain I, Iqubal MK, et al. Intranasally administered pitavastatin ameliorates pentylenetetrazol-induced neuroinflammation, oxidative stress and cognitive dysfunction. Life Sci. 2018;211:172\u201381.","journal-title":"Life Sci"},{"key":"1285_CR135","doi-asserted-by":"publisher","first-page":"13769","DOI":"10.1074\/jbc.M700078200","volume":"282","author":"A Hamik","year":"2007","unstructured":"Hamik A, Lin Z, Kumar A, Balcells M, Sinha S, Katz J, et al. Kruppel-like factor 4 regulates endothelial inflammation. J Biol Chem. 2007;282:13769\u201379.","journal-title":"J Biol Chem"},{"key":"1285_CR136","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1586\/ern.13.49","volume":"13","author":"P Curatolo","year":"2013","unstructured":"Curatolo P, Moavero R. mTOR inhibitors as a new therapeutic option for epilepsy. Expert Rev Neurother. 2013;13:627\u201338.","journal-title":"Expert Rev Neurother"},{"key":"1285_CR137","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1111\/j.1528-1167.2012.03513.x","volume":"53","author":"EA Van Vliet","year":"2012","unstructured":"Van Vliet EA, Forte G, Holtman L, Den Burger JCG, Sinjewel A, De Vries HE, et al. Inhibition of mammalian target of rapamycin reduces epileptogenesis and blood-brain barrier leakage but not microglia activation. Epilepsia 2012;53:1254\u201363.","journal-title":"Epilepsia"},{"key":"1285_CR138","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1093\/cvr\/cvu183","volume":"104","author":"IS Kwon","year":"2014","unstructured":"Kwon IS, Wang W, Xu S, Jin ZG. Histone deacetylase 5 interacts with Kr\u00fcppel-like factor 2 and inhibits its transcriptional activity in endothelium. Cardiovasc Res. 2014;104:127\u201337.","journal-title":"Cardiovasc Res"},{"key":"1285_CR139","doi-asserted-by":"publisher","first-page":"6581","DOI":"10.7314\/APJCP.2014.15.16.6581","volume":"15","author":"S Zohre","year":"2014","unstructured":"Zohre S, Kazem NK, Abolfazl A, Mohammad RY, Aliakbar M, Alizadeh E, et al. Trichostatin A-induced apoptosis is mediated by Kruppel-like factor 4 in ovarian and lung cancer. Asian Pac J Cancer Prev. 2014;15:6581\u20136.","journal-title":"Asian Pac J Cancer Prev"},{"key":"1285_CR140","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/cdd.2015.85","volume":"23","author":"T Yu","year":"2016","unstructured":"Yu T, Chen X, Zhang W, Liu J, Avdiushko R, Napier DL, et al. KLF4 regulates adult lung tumor-initiating cells and represses K-Ras-mediated lung cancer. Cell Death Differ. 2016;23:207\u201315.","journal-title":"Cell Death Differ"},{"key":"1285_CR141","doi-asserted-by":"publisher","first-page":"105226","DOI":"10.1016\/j.phrs.2020.105226","volume":"162","author":"J Bicker","year":"2020","unstructured":"Bicker J, Alves G, Fonseca C, Falc\u00e3o A, Fortuna A. Repairing blood-CNS barriers: future therapeutic approaches for neuropsychiatric disorders. Pharm Res. 2020;162:105226.","journal-title":"Pharm Res"},{"key":"1285_CR142","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1038\/mt.2012.117","volume":"20","author":"D Moschidou","year":"2012","unstructured":"Moschidou D, Mukherjee S, Blundell MP, Drews K, Jones GN, Abdulrazzak H, et al. Valproic acid confers functional pluripotency to human amniotic fluid stem cells in a transgene-free approach. Mol Ther. 2012;20:1953\u201367.","journal-title":"Mol Ther"},{"key":"1285_CR143","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1016\/j.yjmcc.2009.08.022","volume":"47","author":"HJ Kee","year":"2009","unstructured":"Kee HJ, Kook H. Kr\u00fcppel-like factor 4 mediates histone deacetylase inhibitor-induced prevention of cardiac hypertrophy. J Mol Cell Cardiol. 2009;47:770\u201380.","journal-title":"J Mol Cell Cardiol"},{"key":"1285_CR144","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.bbrc.2007.06.116","volume":"360","author":"SJ Kim","year":"2007","unstructured":"Kim SJ, Lee BH, Lee YS, Kang KS. Defective cholesterol traffic and neuronal differentiation in neural stem cells of Niemann-Pick type C disease improved by valproic acid, a histone deacetylase inhibitor. Biochem Biophys Res Commun. 2007;360:593\u20139.","journal-title":"Biochem Biophys Res Commun"},{"key":"1285_CR145","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1111\/epi.17210","volume":"63","author":"EA van Vliet","year":"2022","unstructured":"van Vliet EA, Marchi N. Neurovascular unit dysfunction as a mechanism of seizures and epilepsy during aging. Epilepsia 2022;63:1297\u2013313.","journal-title":"Epilepsia"},{"key":"1285_CR146","doi-asserted-by":"publisher","first-page":"4301","DOI":"10.1523\/JNEUROSCI.2751-17.2018","volume":"38","author":"RG Rempe","year":"2018","unstructured":"Rempe RG, Hartz AMS, Soldner ELB, Sokola BS, Alluri SR, Abner EL, et al. Matrix metalloproteinase-mediated blood-brain barrier dysfunction in epilepsy. J Neurosci. 2018;38:4301\u201315.","journal-title":"J Neurosci"}],"container-title":["Acta Pharmacologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41401-024-01285-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-024-01285-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-024-01285-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,22]],"date-time":"2024-08-22T11:36:23Z","timestamp":1724326583000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41401-024-01285-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,29]]},"references-count":146,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["1285"],"URL":"https:\/\/doi.org\/10.1038\/s41401-024-01285-w","relation":{},"ISSN":["1671-4083","1745-7254"],"issn-type":[{"value":"1671-4083","type":"print"},{"value":"1745-7254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,29]]},"assertion":[{"value":"22 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}